Tech Company Financing Transactions

Shasqi Funding Round

Shasqi closed a $50 million Series B investment round on 11/12/2021. Investors included private investors.

Transaction Overview

Company Name
Announced On
11/12/2021
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series B
Investors

private investors (Juan Jaen)

private investors (William Rieflin)

Proceeds Purpose
The funds will be used to advance the Phase 1/2 clinical study of SQ3370 for the treatment of injectable, advanced solid tumors, and will enable Shasqi to expand its click chemistry platform to create therapeutics that do not require intratumoral injections.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
665 3rd St. 250
San Francisco, CA 94107
USA
Phone
Undisclosed
Email Address
Overview
Shasqi, Inc., founded in 2018, is a privately held company focused on developing cancer treatments using bioorthogonal click chemistry for localized drug delivery. Shasqi's treatments employ activating agents in an injected biomaterial to concentrate and activate systemic prodrug versions of cancer drugs directly at the tumor site.
Profile
Shasqi LinkedIn Company Profile
Social Media
Shasqi Company Twitter Account
Company News
Shasqi News
Facebook
Shasqi on Facebook
YouTube
Shasqi on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
José Oneto
  José Oneto LinkedIn Profile  José Oneto Twitter Account  José Oneto News  José Oneto on Facebook


 

 

Browse more venture capital transactions:

Prev: 11/12/2021: Pendo venture capital transaction
Next: 11/12/2021: AtomicVest venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to report on tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary